![](https://monteverdelaw.com/wp-content/uploads/case-logo/biospecifics-technologies-corp.jpg)
BioSpecifics Technologies Corp. (BSTC) relating to its proposed acquisition by Endo International PLC. Under the terms of the agreement, BioSpecifics shareholders will receive $88.50 per share in cash.
BioSpecifics Technologies Corp. (BSTC) relating to its proposed acquisition by Endo International PLC. Under the terms of the agreement, BioSpecifics shareholders will receive $88.50 per share in cash.